A LinkedIn post from HOPPR profiles Innovation Research Scientist Kalina Slavkova, PhD, emphasizing her role in advancing AI-driven medical imaging within the company’s Innovation and Clinical Research Team. The post outlines her academic background in physics and MRI-focused AI research at the University of Pennsylvania and The University of Texas at Austin, as well as postdoctoral work at the University of Pennsylvania and Columbia University.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, Slavkova’s experience spans MRI-based imaging biomarkers for oncology, deep learning methods for contrast synthesis, and tumor segmentation, with a publication record that includes multiple first-author papers. The post notes that she collaborates with clinicians, engineers, and research partners and contributed significantly to HOPPR’s whitepaper on fine-tuning foundation models for medical imaging, suggesting an internal focus on cutting-edge AI techniques.
For investors, the profile suggests HOPPR is investing in high-caliber research talent to strengthen its capabilities in medical image analysis and AI foundation models. This emphasis on advanced clinical research and academic collaboration may enhance the company’s ability to develop differentiated imaging AI solutions, potentially improving its competitive position in the healthcare AI market over the medium to long term.
The highlighted work on fine-tuning foundation models for medical imaging could signal a strategic bet on scalable AI platforms that can be adapted across multiple clinical use cases. If successfully translated into commercial products or partnerships with healthcare providers and research institutions, these efforts may support future revenue opportunities and reinforce HOPPR’s role in the emerging imaging AI ecosystem.